Dose adjustment in renal impairment: Response from Martindale: the Complete Drug Reference

doi:10.1136/bmj.331.7511.292-a

BMJ 2005;331:292-293 (30 July), doi:10.1136/bmj.331.7511.292-a

Letter

Dose adjustment in renal impairment

Response from Martindale: the Complete Drug Reference

The first 150 words of the full text of this article appear below.

EDITOR—Vidal et al highlight some of the difficultiesthat Martindale: the Complete Drug Reference encounters in attemptingto evaluate and summarise the published literature, includingthe licensed prescribing information issued in different countries(p 263).¹

The variation in the details and recommendations is partly explainedby the different primary purpose and audience of the publicationsstudied. The British National Formulary (BNF) is probably thebusy UK healthcare worker's first port of call and as such reflectscurrent licensed prescribing information and expert opinionin the United Kingdom. I imagine that the same is true for theAmerican Hospital Formulary System Drug Information (AHFS DrugInformation) in the United States. For more detail and someprimary references one might consult Martindale, but as itscoverage is international it also reflects a wider range ofopinions than either of the former sources. Inevitably, . . . [Full text of this article]

-->

Sean C Sweetman, editor

Martindale: the Complete Drug Reference, Royal Pharmaceutical Society of Great Britain, London SE1 7JN sean.sweetman@rpsgb.org

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Article

Systematic comparison of four sources of drug information regarding adjustment of dose for renal function: Liat Vidal, Maya Shavit, Abigail Fraser, Mical Paul, and Leonard Leibovici
BMJ 2005 331: 263. [Abstract] [Full Text] [PDF]